Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C17H15NO3 |
| Molecular Weight | 281.3059 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H](C(O)=O)C1=CC=C(C=C1)N2CC3=CC=CC=C3C2=O
InChI
InChIKey=RJMIEHBSYVWVIN-NSHDSACASA-N
InChI=1S/C17H15NO3/c1-11(17(20)21)12-6-8-14(9-7-12)18-10-13-4-2-3-5-15(13)16(18)19/h2-9,11H,10H2,1H3,(H,20,21)/t11-/m0/s1
| Molecular Formula | C17H15NO3 |
| Molecular Weight | 281.3059 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Dexindoprofen is a non-steroidal drug that has analgesic and anti-inflammatory properties. Dexindoprofen is the dextrorotatory stereo-isomer of indoprofen, to which it has a similar adverse effect pattern. Gastrointestinal and nervous system effects and skin reactions are the most frequent. Following reports of severe gastrointestinal bleeding and carcinogenicity in animals indoprofen was withdrawn from the market worldwide.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:50:29 GMT 2025
by
admin
on
Wed Apr 02 08:50:29 GMT 2025
|
| Record UNII |
004T8726AU
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Wed Apr 02 08:50:29 GMT 2025 , Edited by admin on Wed Apr 02 08:50:29 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000083406
Created by
admin on Wed Apr 02 08:50:29 GMT 2025 , Edited by admin on Wed Apr 02 08:50:29 GMT 2025
|
PRIMARY | |||
|
C77353
Created by
admin on Wed Apr 02 08:50:29 GMT 2025 , Edited by admin on Wed Apr 02 08:50:29 GMT 2025
|
PRIMARY | |||
|
5329
Created by
admin on Wed Apr 02 08:50:29 GMT 2025 , Edited by admin on Wed Apr 02 08:50:29 GMT 2025
|
PRIMARY | |||
|
SUB07032MIG
Created by
admin on Wed Apr 02 08:50:29 GMT 2025 , Edited by admin on Wed Apr 02 08:50:29 GMT 2025
|
PRIMARY | |||
|
DTXSID101018148
Created by
admin on Wed Apr 02 08:50:29 GMT 2025 , Edited by admin on Wed Apr 02 08:50:29 GMT 2025
|
PRIMARY | |||
|
68700
Created by
admin on Wed Apr 02 08:50:29 GMT 2025 , Edited by admin on Wed Apr 02 08:50:29 GMT 2025
|
PRIMARY | |||
|
004T8726AU
Created by
admin on Wed Apr 02 08:50:29 GMT 2025 , Edited by admin on Wed Apr 02 08:50:29 GMT 2025
|
PRIMARY | |||
|
53086-13-8
Created by
admin on Wed Apr 02 08:50:29 GMT 2025 , Edited by admin on Wed Apr 02 08:50:29 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106252
Created by
admin on Wed Apr 02 08:50:29 GMT 2025 , Edited by admin on Wed Apr 02 08:50:29 GMT 2025
|
PRIMARY | |||
|
m771
Created by
admin on Wed Apr 02 08:50:29 GMT 2025 , Edited by admin on Wed Apr 02 08:50:29 GMT 2025
|
PRIMARY | Merck Index | ||
|
258-351-2
Created by
admin on Wed Apr 02 08:50:29 GMT 2025 , Edited by admin on Wed Apr 02 08:50:29 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
RACEMATE -> ENANTIOMER |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
